Dolo V - Search Results

1

Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment.

Festuccia C, Gravina GL, Muzi P, Millimaggi D, Dolo V, Vicentini C, Ficorella C, Ricevuto E, Bologna M. Festuccia C, et al. Among authors: dolo v. Prostate. 2009 Mar 1;69(4):337-45. doi: 10.1002/pros.20884. Prostate. 2009. PMID: 19016477

2

Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line.

Dolo V, Ginestra A, Violini S, Miotti S, Festuccia C, Miceli D, Migliavacca M, Rinaudo C, Romano FM, Brisdelli F, Canevari S, Pavan A, Vittorelli ML. Dolo V, et al. Oncol Res. 1997;9(3):129-38. Oncol Res. 1997. PMID: 9220498

3

Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.

Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M. Festuccia C, et al. Among authors: dolo v. Clin Exp Metastasis. 1998 Aug;16(6):513-28. doi: 10.1023/a:1006590217724. Clin Exp Metastasis. 1998. PMID: 9872599

4

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A. Dolo V, et al. Clin Exp Metastasis. 1999 Mar;17(2):131-40. doi: 10.1023/a:1006500406240. Clin Exp Metastasis. 1999. PMID: 10411105

5

Specific neurons of brain cortex and cerebellum are PIPPin positive.

Nastasi T, Muzi P, Beccari S, Bellafiore M, Dolo V, Bologna M, Cestelli A, Di Liegro I. Nastasi T, et al. Among authors: dolo v. Neuroreport. 2000 Jul 14;11(10):2233-6. doi: 10.1097/00001756-200007140-00034. Neuroreport. 2000. PMID: 10923677

6

Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Angelucci A, D'Ascenzo S, Festuccia C, Gravina GL, Bologna M, Dolo V, Pavan A. Angelucci A, et al. Among authors: dolo v. Clin Exp Metastasis. 2000;18(2):163-70. doi: 10.1023/a:1006778000173. Clin Exp Metastasis. 2000. PMID: 11235992

7

Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.

Violini S, D'Ascenzo S, Bagnoli M, Millimaggi D, Miotti S, Canevari S, Pavan A, Dolo V. Violini S, et al. Among authors: dolo v. J Exp Clin Cancer Res. 2004 Mar;23(1):83-91. J Exp Clin Cancer Res. 2004. PMID: 15149155

8

Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment.

D'Ascenzo S, Giusti I, Millimaggi D, Marci R, Tatone C, Cardigno Colonna R, Moscarini M, Pavan A, Dolo V, Caserta D. D'Ascenzo S, et al. Among authors: dolo v. Eur J Endocrinol. 2004 Jul;151(1):87-91. doi: 10.1530/eje.0.1510087. Eur J Endocrinol. 2004. PMID: 15248826

9

Shedding of membrane vesicles by tumor and endothelial cells.

Dolo V, D'Ascenzo S, Giusti I, Millimaggi D, Taraboletti G, Pavan A. Dolo V, et al. Ital J Anat Embryol. 2005;110(2 Suppl 1):127-33. Ital J Anat Embryol. 2005. PMID: 16101030

10

Alterations of choline phospholipid metabolism in ovarian tumor progression.

Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F. Iorio E, et al. Among authors: dolo v. Cancer Res. 2005 Oct 15;65(20):9369-76. doi: 10.1158/0008-5472.CAN-05-1146. Cancer Res. 2005. PMID: 16230400 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters